New Issue: HSBC sells $353,000 autocallable barrier notes with step-up premium on indexes, ETF

Chicago, June 8 – HSBC USA Inc. priced $353,000 of 0% autocallable barrier notes with step-up premium due Nov. 29, 2024 linked to the performance of the SPDR S&P Biotech ETF, the Russell 2000 index and the Nasdaq-100 index, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will be called at par plus an annual 15.2% call premium if each underlier closes at or above its initial level on any quarterly observation date after one year.

If the notes are not called, the payout will be par unless any underlier finishes below its 70% barrier level, in which case investors will lose 1% for each 1% decline of the worst performer from its initial level.

HSBC Securities (USA) Inc. is the agent.

Issuer:	HSBC USA Inc.
Issue:	Autocallable barrier notes with step-up premium
Underlying assets:	SPDR S&P Biotech ETF, Russell 2000 index and Nasdaq-100 index
Amount:	$353,000
Maturity:	Nov. 29, 2024
Coupon:	0%
Price:	Par
Payout at maturity:	Par unless any underlier finishes below barrier level, in which case investors will lose 1% for each 1% decline of worst performer from its initial level
Call:	At par plus an annual 15.2% call premium if each underlier closes at or above its initial level on any quarterly observation date after one year
Initial levels:	2,327.855 for Russell, 16,306.72 for Nasdaq, $119.38 for fund
Barrier levels:	1,629.4985 for Russell, 11,414.704 for Nasdaq, $83.566 for fund; 70% of initial levels
Pricing date:	Nov. 23, 2021
Settlement date:	Nov. 29, 2021
Agent:	HSBC Securities (USA) Inc.
Fees:	0.5%
Cusip:	40439JSX4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.